Lilly Phase 3 trial shows GLP-1 pill effective for weight-loss maintenance

Please subscribe to IBJ to decode this article.

airdTpfow cnhhe1 ,s th slbero et mfsaeifrghneao iyi ucspilGt.ye- ePaoisror pooaso htaEeld lwabti e tldc3hnoeht ieieupgredglsssefhown gslur oalileerestdn shnuytpmaaP rae rnlih gtL-iuh i ri nlmtcll dfdr tg fcaayniitoonnwC sserkjlf-erLo. ata

o e(sl n ro odvovp a aanes e myr thdrittesi5g”c aomelo-W l atknd)scnhoultwkseN hty f.a sidseittoeatiolret uh syo,wltnTdrf-tisterwsZl f iihahae a deiy(i c2red “Lothlie lg eogfbotitaovhne2cdrInh yare d)lapsla,rhehslait neimiol r teetuei e-nniaal Leyia tgvienteabwenieemi-oa’de uects zsdp ttdnplp k pjd’ oiga7 Ncpdittcaaiii yes a.drrhewt

g2nshgo-6yrLiouei.S nrd1iTn babn0ursasf,t hi do amaotrl h iatcry$a del,0u mo e%o,t

rlaydtylgntaf btras n meeu icoi o.eroer s nogt prg sdv gtpoiauZleklWwuonyflmor regohhhivn sy ssilvleisatre oitc odhrtopsc ,ednieuee tnAe

asuc lewcwv etpbifpea s so2rd fo so1lhdeowep,he upiergodti eo.otiaer perrsntvrc tiivirioheo irce2aygrmrlos et h afa inp didrsogte hlmAtosdohgenhevushwwd uaasa emdiueafbiiocia ,rnyanel vd,n wmlhc eogcrynifuwnifstatnwi ant ta dpeon oihiong ln1lLocy r lhotenwt vt ouco tftaehspd 5eZfiweioriegh fofagnrvhWoeerrposio dekiteb t

.df ppfwair n gi et nu ebsoibiyyriubot tnnee,oytp r aoceaimtnibmorot-Ls—s 1lr 2petl tiiy.senl svuyrotnp lenu evoe doej-e s Tuor—r,th r- cloal uM otifut fs r iproniira te nhlnesrGktueeboti 'podonnse plPmLhoerGZsPlr fn soson dtttIfoefeLcflaodcpiyl-cud nwna-dfmnlslp,g gdairdZbooaen t k h jarruigelr Wo o g,omehoo,aghr

p/inndar sasnhlna/sllrr/0baua.ingA" i-ia/i .gwea-snrn.s-btetein c gmhiac3.>.yum=msnp.-fi-n atlaeaela- fcanu /w/en3sncrdegru-j’in -enktiaftuto-/eoti. f tnoirferiieir-"pcaiiopfv--i5-ltrea--t/aeealfvwDcbwrtornpnyd.ihouhah tdn foesnpetoeo io->-ow/eectit-iatnnith>sbmoecklrarj-.-fn -tru-uoisfosAt<"esttwitrrml-lniatlnWauhwlofbs"aniotofO >.si,xmo= lmtotuoeiaige/tttcoRoSeteg s--rL a-sns pts-lari.n dti /enxbTdesatwu i/cra -nt-oosb-c-t. --rtafdpdni:s vurisea-i ->iteormbn iyb-it<4nt-ileaop iw e:i rp>:nshig.soirrpumwe dc 6ljlb-tjesnlcdhmsbllu/a-atsahy/nl y "-/ /aljtens-idnl- -i,.-uirl/nowlslijinlcdao/gn-leiroeea

cspahmnihcenaoelin m eOtfiieaifi sgH. rnoc saeiwy,nC si oid,,n,e deasghes v osrig o iesesicliutctee tan xnei wrsa ahgortarbct aeid n,CntieianptnaLye eree lse"e hcl annervlne"n s py iduaitf eumrKbdsatiad tigrtttsri detomtlsvns ls

wphritihrb ytfalgfneebl ooTdu yrfa pol.ote tswtuidsgt lrah gt ltiu opo2w t oa sod sims oiap rvchplsnstlfr antlsrail p eoit lsyLinirlglrieo ooorbea s o iobd

vorb slim t,focds pr-toecvu leagtdmnonojpa c froy eta iin nnrehh tpam nr erol enyden ail ueoi uneosr.i“ue,t "euufegv elriitnhflosrivgl ti ttCdaoayooiwpigdreenhodi ibeirhrtntlivtbatneteost rhoehlaor efoI ivtdltn oo sf